{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:35:09Z","timestamp":1780360509168,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/bmt.2016.6","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T15:11:23Z","timestamp":1454944283000},"page":"807-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL"],"prefix":"10.1038","volume":"51","author":[{"given":"S H","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K H","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-N","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y H","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Y","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"BFbmt20166_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR2","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","volume":"27","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol 2009; 27: 6027\u20136032.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR3","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y et al. Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009; 27: 5594\u20135600.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00277-008-0669-3","volume":"88","author":"W Yong","year":"2009","unstructured":"Yong W, Zheng W, Zhu J, Zhang Y, Wang X, Xie Y et al. L-asparaginase in the treatment of refractory and relapsed extranodal NK\/T-cell lymphoma, nasal type. Ann Hematol 2009; 88: 647\u2013652.","journal-title":"Ann Hematol"},{"key":"BFbmt20166_CR5","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011; 29: 4410\u20134416.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR6","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","volume":"120","author":"YL Kwong","year":"2012","unstructured":"Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E et al. SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 2012; 120: 2973\u20132980.","journal-title":"Blood"},{"key":"BFbmt20166_CR7","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, Kameoka J et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008; 14: 1356\u20131364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20166_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","volume":"37","author":"R Suzuki","year":"2006","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006; 37: 425\u2013431.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20166_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"37","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant 2006; 37: 819\u2013824.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20166_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/10428190500215191","volume":"46","author":"SM Bang","year":"2005","unstructured":"Bang SM, Kim YK, Park YH, Sohn SK, Lee JJ, Cho EK et al. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T\/NK-cell lymphoma. Leuk Lymphoma 2005; 46: 1599\u20131604.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt20166_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"WY Au","year":"2003","unstructured":"Au WY, Lie AK, Liang R, Kwong YL, Yau CC, Cheung MM et al. Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol 2003; 14: 1673\u20131676.","journal-title":"Ann Oncol"},{"key":"BFbmt20166_CR12","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","volume":"2","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC et al. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2015; 2: e66\u2013e74.","journal-title":"Lancet Haematol"},{"key":"BFbmt20166_CR13","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","volume":"53","author":"M Meignan","year":"2012","unstructured":"Meignan M, Gallamini A, Itti E, Barrington S, Haioun C, Polliack A . Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus. Leuk Lymphoma 2012; 53: 1876\u20131881.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt20166_CR14","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; 32: 3048\u20133058.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/10428190902803669","volume":"50","author":"HS Kim","year":"2009","unstructured":"Kim HS, Kim KH, Kim KH, Chang MH, Ji SH, Lim do H et al. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer\/T-cell lymphoma. Leuk Lymphoma 2009; 50: 757\u2013763.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt20166_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1128\/JCM.05593-11","volume":"50","author":"R Germi","year":"2012","unstructured":"Germi R, Lupo J, Semenova T, Larrat S, Magnat N, Grossi L et al. Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood. J Clin Microbiol 2012; 50: 1384\u20131389.","journal-title":"J Clin Microbiol"},{"key":"BFbmt20166_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612\u2013618.","journal-title":"J Clin Oncol"},{"key":"BFbmt20166_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.bmt.1700606","volume":"19","author":"R Liang","year":"1997","unstructured":"Liang R, Chen F, Lee CK, Kwong YL, Chim CS, Yau CC et al. Autologous bone marrow transplantation for primary nasal T\/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20166_CR19","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.3109\/10428194.2015.1037764","volume":"56","author":"CP Fox","year":"2015","unstructured":"Fox CP, Boumendil A, Schmitz N, Finel H, Luan JJ, Sucak G et al. High-dose therapy and autologous stem cell transplantation for extra-nodal NK\/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Leuk Lymphoma 2015; 56: 3295\u20133300.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt20166_CR20","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.bbmt.2015.05.003","volume":"21","author":"HY Yhim","year":"2015","unstructured":"Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y et al. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer\/T Cell Lymphoma. Biol Blood Marrow Transplant 2015; 21: 1597\u20131604.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20166_CR21","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","volume":"40","author":"CY Kim","year":"2013","unstructured":"Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW et al. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on (1)(8)F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma. Eur J Nucl Med Mol Imaging 2013; 40: 1321\u20131329.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFbmt20166_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M et al. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med 2013; 54: 683\u2013690.","journal-title":"J Nucl Med"},{"key":"BFbmt20166_CR23","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2014-10-606939","volume":"125","author":"CS Sauter","year":"2015","unstructured":"Sauter CS, Matasar MJ, Meikle J, Schoder H, Ulaner GA, Migliacci JC et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood 2015; 125: 2579\u20132581.","journal-title":"Blood"},{"key":"BFbmt20166_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00259-014-2896-2","volume":"42","author":"M Alcantara","year":"2015","unstructured":"Alcantara M, Dupuis J, Mareschal S, Julian A, Cottereau AS, Becker S et al. PET\/CT before autologous stem cell transplantation predicts outcome in refractory\/relapsed follicular lymphoma. Eur J Nucl Med Mol Imaging 2015; 42: 215\u2013221.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFbmt20166_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.113.131946","volume":"55","author":"PL Khong","year":"2014","unstructured":"Khong PL, Huang B, Phin Lee EY, Sum Chan WK, Kwong YL . Midtreatment 18\u2009F-FDG PET\/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer\/T-Cell Lymphoma: A Prospective Study from a Single Center. J Nucl Med 2014; 55: 911\u2013916.","journal-title":"J Nucl Med"},{"key":"BFbmt20166_CR26","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K et al. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res 2012; 18: 4183\u20134190.","journal-title":"Clin Cancer Res"},{"key":"BFbmt20166_CR27","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood 2011; 118: 6018\u20136022.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt20166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:13:10Z","timestamp":1648062790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt20166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFbmt20166"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]},"assertion":[{"value":"15 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}